Multiconsult ASA reported a 7.8% increase in net operating revenues to NOK 1,527.1 million in Q2 2026, driven by higher billing rates and increased capacity. EBITA rose to NOK 108.2 million, improving the margin to 7.1%, supported by good sales and strengthened cost control. The company also saw strong order intake and a stable market outlook, with CEO Karsten Warloe emphasizing ongoing efforts to enhance profitability and leverage digital tools like AI. Multiconsult aims for sustained growth and top client experience in the coming years.
Nova Klúbburinn hf. has completed a share buyback program, acquiring 122,699,386 shares at an average price of ISK 3.26 per share. The buyback was part of an inverse offer process with valid bids for 159,526,476 shares. The company accepted bids up t...
Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a significant stock price drop triggered by a new federal kidney care strategy announced by the U.S. Department of Health and Human Services. The plan aims to increas...
3M has agreed to a $7.35 billion nominal settlement, with a present value of $5.8 billion, to resolve approximately 99% of PFAS-related personal injury claims involving up to 120,000 plaintiffs. This settlement reduces litigation uncertainty and alig...
Pomerantz LLP is investigating claims against Evolus, Inc. following an FDA warning about misleading Instagram promotions for its wrinkle treatment Jeuveau. The FDA criticized the ads for minimizing safety risks and making exaggerated claims about th...
Pomerantz LLP is investigating Neogen Corporation following an FDA warning about its veterinary wound care product, Neogen Vet HYCOAT, which was linked to serious infections and at least 20 horse deaths. This represents the largest number of horse de...
